We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Biomarker and Cardiac Function in Sepsis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00800631
Recruitment Status : Unknown
Verified December 2008 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
First Posted : December 2, 2008
Last Update Posted : December 2, 2008
Information provided by:
National Taiwan University Hospital

Brief Summary:
The development and severity of sepsis induced myocardial dysfunction can be monitored from the serum biomarker.

Condition or disease

Study Type : Observational
Estimated Enrollment : 150 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Biomarker and Associated Cardiac Function in the Patients With Sepsis
Study Start Date : January 2008
Estimated Primary Completion Date : January 2009
Estimated Study Completion Date : December 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sepsis
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Inclusion Criteria:

  • Sepsis patients with 2 of the followings when arrival ER and treated > 6 hours:

    • BT >38℃ or<36℃
    • HR >90/min
    • RR >20/min or PaCO2 < 32 mmHg
    • WBC count >12×109/L or <4×109/L or immature form >10%

Exclusion Criteria:

  • Age < 18
  • Major trauma patients
  • Pregnancy
  • Willing to do not aggressive treatment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00800631

Contact: ChiungYuan Hsu, Mph 886-2-23123456 ext 65926 dtemer01@gmail.com

ER of National Taiwan Univeristy Hospital Recruiting
Taipei, Taiwan, 100
Contact: Chiung Yuan Hsu, Mph    886-2-23123456 ext 65926    dtemer01@gmail.com   
Sponsors and Collaborators
National Taiwan University Hospital

Responsible Party: Chiung-Yuan Hsu/ Attending VS of Emergency Department, National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT00800631     History of Changes
Other Study ID Numbers: 200708002R
First Posted: December 2, 2008    Key Record Dates
Last Update Posted: December 2, 2008
Last Verified: December 2008

Additional relevant MeSH terms:
Systemic Inflammatory Response Syndrome
Pathologic Processes